Our collaborative approach to designing and running trials with five of the 13 national cancer cooperative groups is what makes the CTC Oncology group unique. Together, we have successfully secured competitive funding from government and non-government sources to carry out investigator-initiated trials to improve outcomes for patients with cancer.

We have collaborated in over 180 projects and have recruited many thousands of patients in breast, oesophageal, gastric, colorectal, lung, gynaecological, neurological and urogenital cancers locally and globally.

The CTC is the coordinating centre for the:

  • Australasian Gastro-Intestinal Trials Group (AGITG)
  • Australia New Zealand Gynaecological Oncology Group (ANZGOG)
  • Australasian Lung Cancer Trials Group (ALTG)
  • Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP)
  • Cooperative Trials Group for Neuro-Oncology (COGNO)

The CTC also supports the statistical activities of the Australia and New Zealand Breast Cancer Trials Group (BCT) and the Primary Care Collaborative Cancer Clinical Trials Group (PC4).

The CTC covers the full range of responsibilities involved in conducting clinical trials — from assisting in establishing new groups by creating a research governance structure and terms of reference, identifying important questions related to public health, through to large-scale trial operations in collaboration with research groups. These include concept and protocol development, randomisation, data collection, ethics and regulatory compliance, on-site monitoring and audit, and data analyses and manuscript preparation.

For more information, contact our CTC Oncology Co-directors, John Simes or Martin Stockler.

Cancer Divisions